About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
CEO Quarterly Update
October 4, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Newsletter – October 2017
Next Post
Extension of Closing Date of Entitlement Offer
Related Posts
Phosphagenics Signs a Multinational License for TPM® in Personal Care Products
December 4, 2017
Phosphagenics Initiates Arbitration Against Mylan
January 7, 2016
Positive Results for Phase II Topical CBD Osteoarthritis Study
March 29, 2022
March 29, 2022